English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Cell culture-based influenza virus production: suspension or adherent producer cell lines?

Genzel, Y., Lohr, V., Behrendt, I., Scharfenberg, K., Kamen, A., Schiedner, G., et al. (2012). Cell culture-based influenza virus production: suspension or adherent producer cell lines?. Talk presented at Cell line development and engineering 2012. Cologne, Germany. 2012-02-13 - 2012-02-17.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-0013-895F-D Version Permalink: http://hdl.handle.net/11858/00-001M-0000-0025-0AE9-E
Genre: Talk

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Genzel, Yvonne1, Author              
Lohr, Verena1, Author              
Behrendt, Ilona1, Author              
Scharfenberg, Klaus, Author
Kamen, Amine, Author
Schiedner, Gudrun, Author
Jordan, Ingo, Author
Reichl, Udo1, 2, Author              
Affiliations:
1Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140              
2Otto-von-Guericke-Universität Magdeburg, ou_1738156              

Content

show
hide
Free keywords: -
 Abstract: Various cell lines are currently being evaluated for influenza virus production and process performance to find alternatives to the egg-based vaccine manufacturing. Choosing between suspension and adherent cell lines is not easy and requires evaluation of different process concepts. Here, we present a comparison of adherent cell lines (MDCK, Vero) and suspension cell lines (MDCK.SUS2, AGE1.CR, HEK293, CAP) to give insights into the complexity of this choice. The cells were cultivated in various cultivation systems including roller bottles, shaker flasks, small scale stirred tank reactors, and wave bioreactors. Different cultivation strategies were investigated (batch (with or without medium exchange), perfusion), cultivating each cell line in its appropriate medium. Infection with several influenza virus strains using different infection conditions (MOI (multiplicity of infection), trypsin activity) helped to improve virus yields. Data on metabolism, cell growth and virus titer will be discussed for several bioreactor cultivations. It can be seen that a simple screening of cell lines would not lead to satisfactory results concerning the choice of adherent versus suspension cell-based processes and optimum cultivation conditions. In particular, each of the cell lines investigated can produce most influenza strains in acceptable titers after careful adaptation and selection of appropriate process conditions. It remains however unclear, why some virus strains cannot be produced by specific cell lines. Because of this it seems advisable, to have several alternatives for influenza vaccine manufacturing in case of a pandemic threat.

Details

show
hide
Language(s):
 Dates: 2012
 Publication Status: Not specified
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: eDoc: 610106
 Degree: -

Event

show
hide
Title: Cell line development and engineering 2012
Place of Event: Cologne, Germany
Start-/End Date: 2012-02-13 - 2012-02-17

Legal Case

show

Project information

show

Source

show